当前位置: 首页 > 期刊 > 《中国健康月刊·B版》 > 2012年第2期 > 正文
编号:12192767
依达拉奉对心肌缺血再灌注损伤的保护作用研究(2)
http://www.100md.com 2012年2月1日 佟刚 郭鹏 刘日辉 侯少华 徐晶华
第1页

    参见附件(2860KB,2页)。

     参考文献

    [1]Zhang P, Li W,et al.Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.Neuroscience. 2011 Nov 15.

    [2]Kono S, Deguchi K, et al.Tissue Plasminogen Activator Thrombolytic Therapy for Acute Ischemic Stroke in 4 Hospital Groups in Japan.J Stroke Cerebrovasc Dis. 2011 Oct 1.

    [3]Kimura K, Aoki J, et al. Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients - A preliminary study.J Neurol Sci. 2011 Oct 1.

    [4]Xin Y, Zhang S, et al. Electrocardiographic and biochemical evidence for the cardioprotective effect of antioxidants in acute doxorubicin-induced cardiotoxicity in the beagle dogs.Biol Pharm Bull. 2011;34(10):1523-6.

    [5]Yu X, Lu S, et al. The investigation of the interaction between NCP-EDA and bovine serum albumin by spectroscopic approaches. Spectrochim Acta A Mol Biomol Spectrosc. 2011 Dec;83(1):609-13.

    [6] Harada K, Suzuki Y, et al.Combination of Reactive Oxygen Species and Tissue-Type Plasminogen Activator Enhances the Induction of Gelatinase B in Brain Endothelial Cells.Int J Neurosci. 2011 Oct 18.

    [7]Firuzi O, Miri R, et al. Antioxidant therapy: current status and future prospects.Curr Med Chem. 2011 Sep 1;18(25):3871-88.

您现在查看是摘要介绍页,详见PDF附件(2860KB,2页)